PMC:7241991 / 3379-4084
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 52 | 593-622 | Gene | denotes | angiotensin-converting enzyme | Gene:1636 |
| 53 | 635-638 | Gene | denotes | ACE | Gene:1636 |
| 54 | 227-233 | Species | denotes | people | Tax:9606 |
| 55 | 499-507 | Species | denotes | patients | Tax:9606 |
| 56 | 681-689 | Species | denotes | patients | Tax:9606 |
| 57 | 557-565 | Chemical | denotes | calcium- | MESH:D002118 |
| 58 | 105-113 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 59 | 202-214 | Disease | denotes | hypertension | MESH:D006973 |
| 60 | 283-295 | Disease | denotes | Hypertension | MESH:D006973 |
| 61 | 535-547 | Disease | denotes | hypertension | MESH:D006973 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T12 | 105-113 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T13 | 202-214 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
| T14 | 283-295 | Disease | denotes | Hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
| T15 | 535-547 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T16 | 146-149 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T17 | 313-314 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T18 | 337-340 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T2 | 557-581 | Chemical | denotes | calcium-channel blockers | http://purl.obolibrary.org/obo/CHEBI_38215 |
| T3 | 557-564 | Chemical | denotes | calcium | http://purl.obolibrary.org/obo/CHEBI_22984|http://purl.obolibrary.org/obo/CHEBI_29320 |
| T5 | 593-633 | Chemical | denotes | angiotensin-converting enzyme inhibitors | http://purl.obolibrary.org/obo/CHEBI_35457 |
| T6 | 593-604 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
| T7 | 616-633 | Chemical | denotes | enzyme inhibitors | http://purl.obolibrary.org/obo/CHEBI_23924 |
| T8 | 623-633 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T9 | 635-638 | Chemical | denotes | ACE | http://purl.obolibrary.org/obo/CHEBI_35457 |
| T10 | 640-650 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T21 | 0-282 | Sentence | denotes | In making the case for the possibility of innate biological health differences between groups during the COVID-19 crisis, at least one researcher has pointed to the already-recognised increased risk of hypertension among black people of Afro-Caribbean descent in the UK and the USA. |
| T22 | 283-371 | Sentence | denotes | Hypertension is an example of a health condition that has been unambiguously racialised. |
| T23 | 372-705 | Sentence | denotes | It is so widely accepted as such that the UK National Institute for Health and Care Excellence guidelines recommend that black patients younger than 55 years with hypertension be given calcium-channel blockers instead of angiotensin-converting enzyme inhibitors (ACE) inhibitors, which are given to non-black patients under 55 years. |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 202-214 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
| T2 | 283-295 | Phenotype | denotes | Hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
| T3 | 535-547 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |